Literature DB >> 3314498

Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation.

L W Stevenson1, M B Fowler, J S Schroeder, W G Stevenson, K A Dracup, V Fond.   

Abstract

Although the success of cardiac transplantation has encouraged earlier referral of potential candidates, those with mild symptoms of heart failure are frequently considered "too well" for transplantation. Outcome was investigated for 28 patients with non-ischemic dilated cardiomyopathy and ejection fraction of 25 percent or less who were denied transplantation due to lack of severe symptoms. One-year survival without transplantation was 46 percent. Low stroke volume and history of ventricular arrhythmias were independent predictors of early mortality. High risk, defined as either stroke volume of 40 ml or less or history of ventricular arrhythmia, identified 13 of 14 patients who did not survive one year and only one of 12 one-year survivors (p less than 0.001). Low stroke volume predicted hemodynamic failure (p less than 0.05) whereas arrhythmic history predicted sudden death (p less than 0.001). Clinical status improved in only six patients, all of whom had symptom duration of seven or less months at initial evaluation (p less than 0.001). Thus, patients referred to transplantation for dilated cardiomyopathy with an ejection fraction of 25 percent or less have a poor prognosis even if symptoms are mild. Patients with high hemodynamic risk may require early transplantation, whereas those with high arrhythmia risk may require other aggressive therapy in order to avoid transplantation until symptoms become severe.

Entities:  

Mesh:

Year:  1987        PMID: 3314498     DOI: 10.1016/0002-9343(87)90644-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Surgical alternatives to transplantation and assist devices in the treatment of heart failure.

Authors:  J J DeRose; M C Oz
Journal:  Curr Cardiol Rep       Date:  2000-11       Impact factor: 2.931

Review 2.  Cardiac transplantation. Selection, immunosuppression, and survival.

Authors:  L W Stevenson; H Laks; P I Terasaki; B D Kahan; D C Drinkwater
Journal:  West J Med       Date:  1988-11

Review 3.  Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.

Authors:  F Andersson; C Cline; T Rydén-Bergsten; L Erhardt
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

4.  Effectiveness of long-term beta-blocker therapy for dilated cardiomyopathy--echocardiographical follow-up.

Authors:  M Fukunami; K Hashimura; M Ohmori; T Ikeda; K Umemoto; K Kumagai; A Sakai; T Yamada; N Kondoh; T Minamino
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

5.  Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.

Authors:  M H Anderson; A J Camm
Journal:  Br Heart J       Date:  1993-01

6.  Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy.

Authors:  I L Kron; T L Flanagan; L H Blackbourne; R A Schroeder; S P Nolan
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

Review 7.  Mitral valve reconstruction in the patient with heart failure.

Authors:  S F Bolling
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

Review 8.  Surgical treatment of functional mitral regurgitation in dilated cardiomyopathy.

Authors:  Hussein S Al-Amri; Abdulrahman M Al-Moghairi; Rieda M El Oakley
Journal:  J Saudi Heart Assoc       Date:  2011-04-16

Review 9.  Prevalence and incidence of arrhythmias and sudden death in heart failure.

Authors:  John G F Cleland; Sudipta Chattopadhyay; Aleem Khand; Timothy Houghton; Gerald C Kaye
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.